Verenium Corporation
4955 Directors Place
San Diego
California
92121
United States
Tel: 800-526-5000
Website: http://www.verenium.com/
About Verenium Corporation
Verenium Corporation (Nasdaq: VRNM) was formed in June of 2007 through the merger of Diversa Corporation, a global leader in industrial enzyme discovery and development, and Celunol Corporation, a company on the forefront of developing cellulosic ethanol.
Verenium is using its proprietary technologies and world-class expertise in pre-treatment, novel enzyme development, fermentation, engineering and project development to accelerate the development and commercialization of cellulosic ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste and wood products.
By using theses integrated end-to-end capabilities, Verenium is positioned to be the first to produce cellulosic ethanol on a commercial-scale.
In addition, the Company discovers and optimizes enzymes, proteins that act as the catalysts of biochemical reactions, for the biofuels, specialty industrial processes and health & nutrition markets. Verenium currently has a portfolio of commercialized enzyme products as well as several late-stage product candidates.
For more information on Verenium, please visit www.verenium.com.
149 articles about Verenium Corporation
-
Be The Match BioTherapies Strengthens Business Development Team With New Hires
6/28/2018
Be The Match BioTherapies® today announced the appointment of Mark Flower as Vice President, Business Development and Strategic Partnerships, and Erin Rasch as Senior Director, Sales and New Business Development.
-
Verenium Corporation To Sponsor And Present At The 2013 Biotechnology Industry Organization (BIO) Pacific Rim Summit On Industrial Biotechnology And Bioenergy
12/2/2013
-
BASF Pays About $51.2 Million for Verenium Corporation; Verenium Stock Rises +58.17% at Market Close (September 20, 2013)
9/20/2013
-
Verenium Corporation to Present at the Rodman & Renshaw Annual Global Investment Conference
9/4/2013
-
Verenium Corporation Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2013
8/8/2013
-
Verenium Corporation to Present at Two Upcoming Conferences
8/1/2013
-
Novus International and Verenium Corporation Introduce the Newest Addition to Novus's Enzyme Solutions Portfolio: CIBENZA® PHYTAVERSE™
7/26/2013
-
Verenium Corporation to Announce Second Quarter 2013 Financial Results
7/25/2013
-
Verenium Corporation to Sponsor and Present at the 2013 Bio World Congress on Industrial Biotechnology
6/11/2013
-
Verenium Corporation Announces Appointment of Brian Carter as Vice President of Grain Processing
6/10/2013
-
Verenium Corporation to Introduce New Enzyme Product at 2013 International Fuel Ethanol Workshop & Expo
5/28/2013
-
Verenium Corporation to Present at Two Upcoming Conferences
5/23/2013
-
Verenium Corporation Reports Financial Results For the First Quarter Ended March 31, 2013
5/10/2013
-
Verenium Corporation to Announce First Quarter 2013 Financial Results
5/2/2013
-
Verenium Corporation Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3/28/2013
-
Verenium Corporation to Announce Fourth Quarter and Year End 2012 Financial Results
3/18/2013
-
Verenium Corporation Announces Preliminary Financial Results For Fiscal 2012
3/15/2013
-
Verenium Corporation to Present at the 25Th Annual Roth Conference
3/12/2013
-
Verenium Corporation Appoints Holger Liepmann to its Board of Directors
2/26/2013
-
Verenium Corporation to Sponsor the Renewable Fuels Association 18th Annual National Ethanol Conference
2/4/2013